Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone + bupropion for weight regain or insufficient weight loss after bariatric surgery
RBR-789gmdfPhase 4Completed
- Sponsor
- Santa Casa de Misericórdia de São Paulo
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of naltrexone and bupropion in obesity, sponsored by Santa Casa de Misericórdia de São Paulo. Started Apr 2024; status: completed.
02
Drugs
naltrexonebupropion
03
Conditions
obesity
Beyond the preview
Go deeper on RBR-789gmdf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-789gmdf.